Whitehawk Therapeutics (WHWK) Total Liabilities (2018 - 2025)
Historic Total Liabilities for Whitehawk Therapeutics (WHWK) over the last 8 years, with Q3 2025 value amounting to $9.8 million.
- Whitehawk Therapeutics' Total Liabilities fell 4147.95% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year decrease of 4147.95%. This contributed to the annual value of $17.8 million for FY2024, which is 3447.55% down from last year.
- Whitehawk Therapeutics' Total Liabilities amounted to $9.8 million in Q3 2025, which was down 4147.95% from $8.8 million recorded in Q2 2025.
- Whitehawk Therapeutics' Total Liabilities' 5-year high stood at $27.2 million during Q4 2023, with a 5-year trough of $2.1 million in Q1 2021.
- In the last 5 years, Whitehawk Therapeutics' Total Liabilities had a median value of $19.8 million in 2023 and averaged $17.6 million.
- Per our database at Business Quant, Whitehawk Therapeutics' Total Liabilities surged by 80150.11% in 2022 and then plummeted by 6164.53% in 2025.
- Over the past 5 years, Whitehawk Therapeutics' Total Liabilities (Quarter) stood at $21.5 million in 2021, then increased by 20.25% to $25.9 million in 2022, then grew by 5.29% to $27.2 million in 2023, then crashed by 34.48% to $17.8 million in 2024, then crashed by 44.8% to $9.8 million in 2025.
- Its Total Liabilities was $9.8 million in Q3 2025, compared to $8.8 million in Q2 2025 and $12.3 million in Q1 2025.